The National Science Foundation (NSF) has awarded Jeremiah Zartman, a junior faculty member in the College of Engineering, with the Early Career Development Award (CAREER). Honoring outstanding research and the integration of education and research within their individual organizations, the CAREER Award is the most prestigious award given by the U.S. government to young faculty in engineering and science.
Robert A. Schulz, Notre Dame Professor of Biological Sciences receives a 2-year grant from the National Institute Health for a project entitled “Stress induction of a cellular immune response in Drosophila.”
Joel Boerckel, Assistant Professor of the Department of Aerospace and Mechanical Engineering, was awarded a Collaboration in Translational Research grant for a study entitled “Mechanical Regulation of Neovascularization.”
Pinar Zorlutuna, Assistant Professor of Aerospace and Mechanical Engineering, will receive the “Rising Star” Award at the 2016 Biomedical Engineering Society - Cellular and Molecular Bioengineering (CMBE) and Advanced Biomanufacturing (ABioM) Joint Conference.
From stem cells to population ecology, the research topics studied by both students and professors at Notre Dame is exceedingly diverse. Talk Science, a monthly event hosted by Scientia, the student-run journal of undergraduate scientific research at Notre Dame, aims to highlight research opportunities on campus for interested undergraduates to explore.
Jonathan Jou, a junior biological sciences major, is the distinguished recipient of a fellowship to perform research this summer at the Harvard Stem Cell Institute (HSCI) in Cambridge, MA. Jou was selected from a highly competitive applicant pool, open to current students at Harvard or any college or university across the United States and internationally, to participate in the HSCI Summer Internship Program (HIP).
Building on the momentum of its recent Strategic Research Investment initiative — which committed $80 million in internal resources to 14 research projects — the University of Notre Dame has announced the winning proposals in a new strategic hiring initiative. The initiative, which is a key component in the University’s Advancing Our Vision program, will create approximately 80 faculty positions in 10 key areas of research across campus, drawing on $10 million in annual funds that have been reallocated from lower-priority expenditures to this academic priority.
Alumnus Michael Gallagher and his wife, Elizabeth, have made a $5 million gift to establish the Elizabeth and Michael Gallagher Family Professorships in Adult Stem Cell Research at the University of Notre Dame.
Their gift, which will fund three new endowed professorships in adult and all forms of non-embryonic stem cell research, will strengthen Notre Dame’s leadership in the field of stem cell research and enhance the University’s effective dialogue between the biomedical research community and the Catholic Church on matters related to the use and application of stem cells and regenerative medicine.
Two Notre Dame faculty members have traveled to Rome to join some 350 international participants at a Vatican conference on adult stem cell research which begins today (Nov. 9).
Historian and philosopher Philip Sloan, professor emeritus in Notre Dame’s Program of Liberal Studies, and biologist David Hyde, the Rev. Howard J. Kenna, C.S.C., Memorial Director of Notre Dame’s Center for Zebrafish Research, will be among the scientists, religious leaders, policymakers, academics and medical patients attending the two-day conference, “Adult Stem Cells: Science and the Future of Man and Culture.”
Some of the world’s leading scholars across a variety of relevant disciplines are visiting the University of Notre Dame for a week-long “Workshop on Adult and Non-embryonic Stem Cell Research,” being held on campus through July 2.
“The initiative seeks to demonstrate that respect for the equal dignity of every human being – from conception to natural death – and a commitment to excellence and rigor in research are both integral and complementary goods necessary to pursuing the proper ends of biomedical science,” said Carter Snead, professor of law and one of the workshop leaders.
Notre Dame Associate Professor of Law O. Carter Snead, along with Professor Philip Sloan in Notre Dame’s Program of Liberal Studies and Graduate Program in History and Philosophy of Science, was awarded a $50,000 seed grant from the University’s Initiative in Adult Stem Cell Research and Ethics.
President Obama’s decision to sign an executive order Monday easing restrictions on federal funding for embryonic stem cell research comes on the heels on an announcement last week in the journal Nature of a promising alternative to embryonic stem cells. Research by University of Notre Dame biologist Malcolm J. Fraser Jr. provided a crucial key in establishing the practicality of the alternative method.
Stem cells are the body’s master cells, producing all of its tissues and organs. They offer hope for regeneration of tissues and even organs and for curing many diseases.
Just-published research on the generation of cells that function identically to embryonic stem cellshas solved one of the most vexed issues at the intersection of science, ethics and public policy,according to Carter Snead, associate professor of law at the University of Notre Dame Law School and former general counsel…
Dr. William B. Hurlbut, physician and consulting professor in the Program in Human Biology at Stanford University and a member of the Presidents Council on Bioethics, will give a lecture on the ethical implications of harvesting human embryonic stem cells at 4:30 p.m. Tuesday (April 18) in the University…
O. Carter Snead, associate professor of law in theNotre DameLawSchool, will give a lecture onSpeaking Truthfully About Stem Cell Research and Human Cloningat4 p.m.Nov. 16 (Wednesday) in the McKenna Hall auditorium on campus. p. Snead, who was graduated fromSt. JohnsCollegein 1996, earned his law degree fromGeorgetownUniversityin 1999.He served as…
Current research on embryonic stem cells has touched off a debate reaching into the presidential campaign, but experts say it will be a long time before the research leads to cures for diseases such as Parkinsons and Alzheimers. In fact, they note, scientists working with embryonic stem cells have not…